The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae : Importance of Inadequate Initial Antimicrobial Treatment
Open accessAbstract
Bloodstream infections (BSI) caused by extended-spectrum β-lactamase (ESBL)-producing organisms markedly increase the rates of treatment failure and death. We conducted a retrospective cohort analysis to identify risk factors for mortality in adult in-patients with BSI caused by ESBL-producing Enterobacteriaceae (ESBL-BSI). Particular attention was focused on defining the impact on the mortality of inadequate initial antimicrobial therapy (defined as the initiation of treatment with active antimicrobial agents >72 h after collection of the first positive blood culture). A total of 186 patients with ESBL-BSI caused by Escherichia coli ( n = 104), Klebsiella pneumoniae ( n = 58), or Proteus mirabilis ( n = 24) were identified by our microbiology laboratory from 1 January 1999 through 31 December 2004. The overall 21-day mortality rate was 38.2% (71 of 186). In multivariate analysis, significant predictors of mortality were inadequate initial antimicrobial therapy (odds ratio [OR] = 6.28; 95% confidence interval [CI] = 3.18 to 12.42; P < 0.001) and unidentified primary infection site (OR = 2.69; 95% CI = 1.38 to 5.27; P = 0.004). The inadequately treated patients (89 of 186 [47.8%]) had a threefold increase in mortality compared to the adequately treated group (59.5% versus 18.5%; OR = 2.38; 95% CI = 1.76 to 3.22; P < 0.001). The regimens most commonly classified as inadequate were based on oxyimino cephalosporin or fluoroquinolone therapy. Prompt initiation of effective antimicrobial treatment is essential in patients with ESBL-BSI, and empirical decisions must be based on a sound knowledge of the local distribution of pathogens and their susceptibility patterns.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Performance standards for antimicrobial susceptibility testing
Ferraro, M. J. (2001) · Cited by 9,667
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
The APACHE III Prognostic System
Knaus, W. A., Wagner, D. P., Draper, E. A., Zimmerman, J. E., Bergner, M., Bastos, P. G., Sirio, C. A., Murphy, D. J., Lotring, T., Damiano, A., et al. (1991) · Chest · doi:10.1378/chest.100.6.1619 · Cited by 3,439
The APACHE III Prognostic System
Teres, D., & Lemeshow, S. (1992) · Chest · doi:10.1378/chest.102.6.1919b · Cited by 2,880
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
Cosgrove, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499406 · Cited by 1,271
Russell, J. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmra043632 · Cited by 1,048
Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/319757 · Cited by 747
Inadequate Antimicrobial Treatment: An Important Determinant of Outcome for Hospitalized Patients
Kollef, M. H. (2000) · Clinical Infectious Diseases · doi:10.1086/314079 · Cited by 635
Paterson, D. L., Ko, W.-C., Gottberg, A. V., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., Klugman, K. P., Bonomo, R. A., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-1-200401060-00008 · Cited by 631
The APACHE III Prognostic System
Knaus, W. A. (1992) · Chest · doi:10.1016/s0012-3692(16)40910-4 · Cited by 626
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., Klugman, K. P., Bonomo, R. A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/420816 · Cited by 571
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Casellas, J. M., Mulazimoglu, L., Klugman, K. P., Bonomo, R. A., Rice, L. B., McCormack, J. G., & Yu, V. L. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.6.2206-2212.2001 · Cited by 546
Wiener, J. (1999) · JAMA · doi:10.1001/jama.281.6.517 · Cited by 485
Schwaber, M. J., Navon-Venezia, S., Kaye, K. S., Ben-Ami, R., Schwartz, D., & Carmeli, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1257-1262.2006 · Cited by 416
qnrB , Another Plasmid-Mediated Gene for Quinolone Resistance
Jacoby, G. A., Walsh, K. E., Mills, D. M., Walker, V. J., Oh, H., Robicsek, A., & Hooper, D. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1178-1182.2006 · Cited by 400
Pitout, J. D. D., Hossain, A., & Hanson, N. D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5715-5721.2004 · Cited by 298
Tumbarello, M., Spanu, T., Sanguinetti, M., Citton, R., Montuori, E., Leone, F., Fadda, G., & Cauda, R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.498-504.2006 · Cited by 283
Self-citationRodriguez-Bano, J., Navarro, M. D., Romero, L., Muniain, M. A., Cueto, M. D., Rios, M. J., Hernandez, J. R., & Pascual, A. (2006) · Clinical Infectious Diseases · doi:10.1086/508877 · Cited by 279
Kang, C.-I., Kim, S.-H., Park, W. B., Lee, K.-D., Kim, H.-B., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4574-4581.2004 · Cited by 267
Extended-Spectrum β-Lactamases and Clinical Outcomes: Current Data
Ramphal, R., & >, P. G. A. (2006) · Clinical Infectious Diseases · doi:10.1086/500663 · Cited by 267
gyrA Mutations Associated with Fluoroquinolone Resistance in Eight Species of Enterobacteriaceae
Weigel, L. M., Steward, C. D., & Tenover, F. C. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2661 · Cited by 250
Schiappa, D. A., Hayden, M. K., Matushek, M. G., Hashemi, F. N., Sullivan, J., Smith, K. Y., Miyashiro, D., Quinn, J. P., Weinstein, R. A., & Trenholme, G. M. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.3.529 · Cited by 248
Pagani, L., Dell'Amico, E., Migliavacca, R., D'Andrea, M. M., Giacobone, E., Amicosante, G., Romero, E., & Rossolini, G. M. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.9.4264-4269.2003 · Cited by 238
Tsay, R.-W., Siu, L. K., Fung, C.-P., & Chang, F.-Y. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.9.1021 · Cited by 220
Blot, S., Vandewoude, K., De Bacquer, D., & Colardyn, F. (2002) · Clinical Infectious Diseases · doi:10.1086/340616 · Cited by 201
Hyle, E. P., Lipworth, A. D., Zaoutis, T. E., Nachamkin, I., Bilker, W. B., & Lautenbach, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1375 · Cited by 194
Asensio, A., Oliver, A., González-Diego, P., Baquero, F., Pérez-Díaz, J. C., Ros, P., Cobo, J., Palacios, M., Lasheras, D., & Cantón, R. (2000) · Clinical Infectious Diseases · doi:10.1086/313590 · Cited by 187
Bartonella quintana and Urban Trench Fever
Ohl, M. E., & Spach, D. H. (2000) · Clinical Infectious Diseases · doi:10.1086/313890 · Cited by 168
Schwaber, M. J., Navon-Venezia, S., Schwartz, D., & Carmeli, Y. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.2137-2139.2005 · Cited by 160
Luzzaro, F., Mezzatesta, M. L., Mugnaioli, C., Perilli, M., Stefani, S., Amicosante, G., Rossolini, G. M., & Toniolo, A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.5.1659-1664.2006 · Cited by 159
Endimiani, A., Luzzaro, F., Brigante, G., Perilli, M., Lombardi, G., Amicosante, G., Rossolini, G. M., & Toniolo, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2598-2605.2005 · Cited by 145
Andes, D. R., & Craig, W. A. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01265.x · Cited by 126
Wong‐Beringer, A., Hindler, J. A., Loeloff, M. J., Queenan, A. M., Lee, N., Pegues, D. A., Quinn, J. P., & Bush, K. (2002) · Clinical Infectious Diseases · doi:10.1086/324742 · Cited by 125
Endimiani, A., Luzzaro, F., Perilli, M., Lombardi, G., Coli, A., Tamborini, A., Amicosante, G., & Toniolo, A. (2004) · Clinical Infectious Diseases · doi:10.1086/380645 · Cited by 112
Johnson, J. R., Kuskowski, M. A., Gajewski, A., Sahm, D. F., & Karlowsky, J. A. (2004) · The Journal of Infectious Diseases · doi:10.1086/425018 · Cited by 105
Anderson, D. J., Engemann, J. J., Harrell, L. J., Carmeli, Y., Reller, L. B., & Kaye, K. S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1715-1720.2006 · Cited by 102
Danel, F., Hall, L. M., Gür, D., & Livermore, D. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.785 · Cited by 90
Spanu, T., Sanguinetti, M., Tumbarello, M., D’Inzeo, T., Fiori, B., Posteraro, B., Santangelo, R., Cauda, R., & Fadda, G. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00433-06 · Cited by 88
Self-citationLuzzaro, F., Mantengoli, E., Perilli, M., et al. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.5.1865-1870.2001 · Cited by 84
Menashe, G. (2001) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540151060806 · Cited by 82
Gavin, P. J., Suseno, M. T., Thomson, R. B., Gaydos, J. M., Pierson, C. L., Halstead, D. C., Aslanzadeh, J., Brecher, S. M., Rotstein, C., Brossette, S. E., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00381-05 · Cited by 75
Zimhony, O., Chmelnitsky, I., Bardenstein, R., Goland, S., Hammer-Muntz, O., Navon‐Venezia, S., & Carmeli, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00218-06 · Cited by 59
Cited by
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Tumbarello, M., Viale, P., Viscoli, C., Trecarichi, E. M., Tumietto, F., Marchese, A., Spanu, T., Ambretti, S., Ginocchio, F., Cristini, F., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis588 · Cited by 1,016
Self-citationCarbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
Pitout, J. D. D., Nordmann, P., & Poirel, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01019-15 · Cited by 852
Rodríguez-Baño, J., Gutiérrez-Gutiérrez, B., Machuca, I., & Pascual, A. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00079-17 · Cited by 704
Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli
Giske, C. G., Monnet, D. L., Cars, O., & Carmeli, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01169-07 · Cited by 610
Metadata
- Authors
- Tumbarello, M., Sanguinetti, M., Montuori, E., Trecarichi, E. M., Posteraro, B., Fiori, B., Citton, R., D'Inzeo, T., Fadda, G., Cauda, R., & Spanu, T.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-06
- Volume
- 51
- Issue
- 6
- Pages
- 1987-1994
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2124945254
- Cited by
- 461
- References
- 46
- FWCI
- 11.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.